STAND. COM. REP. NO. 28

Honolulu, Hawaii

, 2019

RE: H.B. No. 75

H.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Sir:

Your Committee on Health, to which was referred H.B. No. 75 entitled:

"A BILL FOR AN ACT RELATING TO THE BOARD OF PHARMACY,"

begs leave to report as follows:

The purpose of this measure is to improve the effectiveness of health care delivery systems by authorizing the Board of Pharmacy to approve pilot and demonstration research projects for innovative applications in the practice of pharmacy.

The Board of Pharmacy, Daniel K. Inouye College of Pharmacy, and Kaiser Permanente supported this measure. Walgreen Co. provided comments.

Your Committee has amended this measure by:

(1) Removing the provision that authorized the Board of Pharmacy to approve a project that implements a drug take-back program by pharmacies;

(2) Changing the effective date to July 1, 2050, to encourage further discussion; and

(3) Making technical, nonsubstantive amendments for clarity, consistency, and style.

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 75, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 75, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.

Respectfully submitted on behalf of the members of the Committee on Health,

____________________________

JOHN M. MIZUNO, Chair